IDEAS home Printed from https://ideas.repec.org/f/pba977.html
   My authors  Follow this author

Anirban Basu

Personal Details

First Name:Anirban
Middle Name:
Last Name:Basu
Suffix:
RePEc Short-ID:pba977
[This author has chosen not to make the email address public]
http://faculty.washington.edu/basua

Affiliation

(10%) University of Washington -Depts of Pharmacy, Health Services, Economics


https://sop.washington.edu/department-of-pharmacy/pharmaceutical-outcomes-research-policy-program-porpp/about/
Seattle, WA
97229

Research output

as
Jump to: Working papers Articles Software

Working papers

  1. Donghoon Lee & Anirban Basu & Jerome A. Dugan & Pinar Karaca-Mandic, 2024. "Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California," NBER Working Papers 32179, National Bureau of Economic Research, Inc.
  2. Anirban Basu, 2023. "Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics," NBER Working Papers 31632, National Bureau of Economic Research, Inc.
  3. Anirban Basu & Noah Hammarlund & Sara Khor & Aasthaa Bansal, 2021. "Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors," NBER Working Papers 29413, National Bureau of Economic Research, Inc.
  4. Kritee Gujral & Anirban Basu, 2019. "Impact of Rural and Urban Hospital Closures on Inpatient Mortality," NBER Working Papers 26182, National Bureau of Economic Research, Inc.
  5. Alice M. Ellyson & Anirban Basu, 2018. "The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices," NBER Working Papers 24387, National Bureau of Economic Research, Inc.
  6. Caroline S. Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2017. "Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," NBER Working Papers 23842, National Bureau of Economic Research, Inc.
  7. Sungchul Park & Anirban Basu & Norma Coe & Fahad Khalil, 2017. "Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment," NBER Working Papers 24038, National Bureau of Economic Research, Inc.
  8. Anirban Basu & Norma Coe & Cole G. Chapman, 2017. "Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures," NBER Working Papers 23840, National Bureau of Economic Research, Inc.
  9. Kai Yeung & Anirban Basu & Ryan N. Hansen & Sean D. Sullivan, 2016. "Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting," NBER Working Papers 22308, National Bureau of Economic Research, Inc.
  10. Anirban Basu & Norma B. Coe & David E. Grembowski & Larry Kessler, 2014. "Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State," NBER Working Papers 20655, National Bureau of Economic Research, Inc.
  11. Anirban Basu, 2014. "Welfare Implications of Learning Through Solicitation versus Diversification in Health Care," NBER Working Papers 20376, National Bureau of Economic Research, Inc.
  12. Anirban Basu & Andrew M. Jones & Pedro Rosa Dias, 2014. "The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health," NBER Working Papers 20811, National Bureau of Economic Research, Inc.
  13. Anirban Basu, 2012. "Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables," NBER Working Papers 18056, National Bureau of Economic Research, Inc.
  14. Evans, H. & Basu, A, 2011. "Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality," Health, Econometrics and Data Group (HEDG) Working Papers 11/08, HEDG, c/o Department of Economics, University of York.
  15. Anirban Basu, 2011. "Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care," NBER Working Papers 16900, National Bureau of Economic Research, Inc.
  16. Anirban Basu & Tomas J. Philipson, 2010. "The Impact of Comparative Effectiveness Research on Health and Health Care Spending," NBER Working Papers 15633, National Bureau of Economic Research, Inc.
  17. Basu A & Manning WG, 2009. "Estimating Lifetime or Episode-of-illness Costs," Health, Econometrics and Data Group (HEDG) Working Papers 09/12, HEDG, c/o Department of Economics, University of York.
  18. Anirban Basu & Daniel Polsky & Willard G. Manning, 2008. "Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures," NBER Working Papers 14086, National Bureau of Economic Research, Inc.
  19. Anirban Basu & Wesley Yin & G. Caleb Alexander, 2008. "The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures," NBER Working Papers 14413, National Bureau of Economic Research, Inc.
  20. Anirban Basu & James J. Heckman & Salvador Navarro-Lozano & Sergio Urzua, 2007. "Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients," Health, Econometrics and Data Group (HEDG) Working Papers 07/07, HEDG, c/o Department of Economics, University of York.
  21. Willard G. Manning & Anirban Basu & John Mullahy, 2003. "Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data," Working Papers 0313, Harris School of Public Policy Studies, University of Chicago.

Articles

  1. Surrey M. Walton & Anirban Basu & John Mullahy & Samuel Hong & Glen T. Schumock, 2017. "Measuring the Value of Pharmaceuticals in the US Health System," PharmacoEconomics, Springer, vol. 35(1), pages 1-4, January.
  2. Anirban Basu, 2015. "Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables," Stata Journal, StataCorp LP, vol. 15(2), pages 397-410, June.
  3. Basu, Anirban, 2015. "Welfare implications of learning through solicitation versus diversification in health care," Journal of Health Economics, Elsevier, vol. 42(C), pages 165-173.
  4. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Heterogeneity In Action: The Role Of Passive Personalization In Comparative Effectiveness Research," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 359-373, March.
  5. Anirban Basu, 2014. "ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 29(4), pages 671-691, June.
  6. Anirban Basu & Kwun Chuen Gary Chan, 2014. "Can We Make Smart Choices Between Ols And Contaminated Iv Methods?," Health Economics, John Wiley & Sons, Ltd., vol. 23(4), pages 462-472, April.
  7. Anirban Basu & Anupam B. Jena & Dana P. Goldman & Tomas J. Philipson & Robert Dubois, 2014. "Response To Epstein'S Comment On “Heterogeneity In Action”," Health Economics, John Wiley & Sons, Ltd., vol. 23(3), pages 376-378, March.
  8. Basu Anirban, 2013. "Personalized Medicine in the Context of Comparative Effectiveness Research," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 107-120, June.
  9. Bijan J. Borah & Anirban Basu, 2013. "Highlighting Differences Between Conditional And Unconditional Quantile Regression Approaches Through An Application To Assess Medication Adherence," Health Economics, John Wiley & Sons, Ltd., vol. 22(9), pages 1052-1070, September.
  10. Anirban Basu & David Meltzer, 2012. "Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials," PharmacoEconomics, Springer, vol. 30(10), pages 859-868, October.
  11. Basu, Anirban & Jena, Anupam B. & Philipson, Tomas J., 2011. "The impact of comparative effectiveness research on health and health care spending," Journal of Health Economics, Elsevier, vol. 30(4), pages 695-706, July.
  12. Basu, Anirban, 2011. "Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care," Journal of Health Economics, Elsevier, vol. 30(3), pages 549-559, May.
  13. Anirban Basu & Willard G. Manning, 2011. "Erratum: Estimating lifetime or episode‐of‐illness costs under censoring," Health Economics, John Wiley & Sons, Ltd., vol. 20(1), pages 125-126, January.
  14. Anirban Basu & Willard G. Manning, 2010. "Estimating lifetime or episode‐of‐illness costs under censoring," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1010-1028, September.
  15. Terza, Joseph V. & Basu, Anirban & Rathouz, Paul J., 2008. "Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling," Journal of Health Economics, Elsevier, vol. 27(3), pages 531-543, May.
  16. Anirban Basu & Bhakti V. Arondekar & Paul J. Rathouz, 2006. "Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity," Health Economics, John Wiley & Sons, Ltd., vol. 15(10), pages 1091-1107, October.
  17. Basu, Anirban & Meltzer, David, 2005. "Implications of spillover effects within the family for medical cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 24(4), pages 751-773, July.
  18. Anirban Basu, 2005. "Extended generalized linear models: Simultaneous estimation of flexible link and variance functions," Stata Journal, StataCorp LP, vol. 5(4), pages 501-516, December.
  19. Manning, Willard G. & Basu, Anirban & Mullahy, John, 2005. "Generalized modeling approaches to risk adjustment of skewed outcomes data," Journal of Health Economics, Elsevier, vol. 24(3), pages 465-488, May.
  20. Anirban Basu & Willard G. Manning & John Mullahy, 2004. "Comparing alternative models: log vs Cox proportional hazard?," Health Economics, John Wiley & Sons, Ltd., vol. 13(8), pages 749-765, August.
  21. David Meltzer & Jeanette Chung & Anirban Basu, 2002. "Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients?," RAND Journal of Economics, The RAND Corporation, vol. 33(3), pages 447-468, Autumn.

Software components

  1. Anirban Basu, 2014. "IVCHECK: Stata module to choose between OLS and contaminated IV," Statistical Software Components S457840, Boston College Department of Economics.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Rankings

This author is among the top 5% authors according to these criteria:
  1. Euclidian citation score
  2. Breadth of citations across fields

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 21 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (15) 2007-09-30 2008-06-07 2008-06-27 2008-10-28 2009-07-28 2011-04-09 2011-11-21 2014-08-25 2015-01-19 2016-06-18 2017-10-01 2018-04-02 2019-09-02 2021-11-22 2024-04-01. Author is listed
  2. NEP-ECM: Econometrics (6) 2008-06-07 2008-06-27 2011-11-21 2012-05-22 2017-10-01 2023-10-23. Author is listed
  3. NEP-IAS: Insurance Economics (3) 2008-10-28 2017-10-01 2018-01-22
  4. NEP-COM: Industrial Competition (2) 2016-06-18 2018-04-02
  5. NEP-LAB: Labour Economics (2) 2008-10-28 2011-11-21
  6. NEP-AGE: Economics of Ageing (1) 2017-10-01
  7. NEP-BIG: Big Data (1) 2021-11-22
  8. NEP-DCM: Discrete Choice Models (1) 2007-09-30
  9. NEP-EDU: Education (1) 2003-10-20
  10. NEP-EFF: Efficiency and Productivity (1) 2024-04-01
  11. NEP-INO: Innovation (1) 2017-10-01
  12. NEP-POL: Positive Political Economics (1) 2014-12-08
  13. NEP-URE: Urban and Real Estate Economics (1) 2015-01-19

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Anirban Basu should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.